Zohran Mamdani was elected mayor of New York City Tuesday, and his victory speech was anything but an attempt to moderate his ...

Ruzasvir has demonstrated highly potent and pan-genotypic antiviral activity in preclinical (picomolar range) and clinical studies. Ruzasvir has been administered to over 2,100 subjects at daily doses ...

When a mother is anaemic during pregnancy, her child is more likely to be born premature, underweight and with iron ...

Philosophy has always been humanity’s go-to guide for tackling life’s biggest questions. Be it pondering the meaning of ...

Statistically significant and clinically meaningful improvements in mean ACQ-5 scores were reported at week 16 versus placebo ...

Decoupling local tax policies from the federal tax cuts passed by Congress means the city will avoid a revenue hit of nearly ...

Zohran Mamdani, after a triumphant campaign built on progressive ideas and a relentless focus on affordability, will become ...

For people who have experienced a heart attack or stroke, or who are at high risk of one and need further cholesterol ...

From tumor profiling to CAR-T optimization, AI is accelerating discovery and decision-making in immuno-oncology. PICI researchers are leveraging multimodal data and large language models to predict ...

A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies for solid tumors, today announced the presentation of safety and early ...

WEDNESDAY, Oct. 29, 2025 (HealthDay News) -- About 18 percent of urinary tract infections (UTIs) are attributable to zoonotic extraintestinal pathogenic Escherichia coli (ExPEC) strains, according to ...

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ('SELLAS’’ or the 'Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer ...